The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure
Open Access
- 18 March 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (4) , 1021
- https://doi.org/10.1093/ndt/gfh006
Abstract
1Tel Aviv Sourasky Medical Center Department of Nephrology Tel Aviv2Tel Aviv Sorasky Medical Center Department of Cardiology Tel Aviv Israel Email: donald@netviKeywords
This publication has 4 references indexed in Scilit:
- In the erythropoietin era, can we forget alternative or adjunctive therapies for renal anaemia management? The androgen example.Nephrology Dialysis Transplantation, 2003
- The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous ironNephrology Dialysis Transplantation, 2003
- The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyJournal of the American College of Cardiology, 2001
- The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsPublished by Elsevier ,2000